Skip to main content
Find more clinical trials

Tai Ji Quan and Cognitive Function in Mild Cognitive Impairment

Start: October 15, 2019
End: February 28, 2024
Enrollment: 320

What Is This Study About?

Tai ji quan, also known as tai chi, is a mind and body practice involving certain postures, gentle movements, and breathing techniques. This study will compare the effects of a cognitively enhanced tai ji quan intervention with standard tai ji quan and light exercise in older adults with mild cognitive impairment. Participants will either complete a cognitively enhanced tai ji quan intervention (Tai Ji Quan: Moving to Maintain Brain Health) or regular tai ji quan or light exercise activities (i.e., breathing, stretching, and body relaxation) for 24 weeks. Researchers will compare the effects of each intervention on changes in cognitive function and dual-task ability, which is the ability to perform two or more cognitive and motor activities simultaneously while maintaining postural control.

Do I Qualify To Participate in This Study?

Minimum Age: 65 Years

Maximum Age: N/A

Must have:

  • Complaint of memory loss
  • No or very mild dementia (Clinical Dementia Rating Scale score of 0.5 or less)
  • Normal general cognitive function (Mini-Mental State Examination score of 24 or more)
  • Capable of exercising safely, as determined by a healthcare provider

Must NOT have:

  • Having medical conditions likely to compromise survival or prevent physical activity, such as metastatic cancer or severe heart failure
  • Participating in any type of tai ji quan or daily and/or structured vigorous physical activity (e.g., brisk walking for 30 minutes or longer or weight lifting on 3 or more days per week) 3 months prior to the study

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Oregon Research Institute

Source: ClinicalTrials.gov ID: NCT04070703